Breadcrumb

null

COMPAR-EU RCTs Web

Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial

Author: Kaminsky, D. A. Country/countries: United States Number of patients participating in the study: 43 This study was focused on patients living with COPD
Intervention analysed in the study: Monitoring techniques Intervention components: E+MT
See more
Setting of implementation: Outpatient care (hospital) Professionals delivering the intervention: Educator Targeted self-management behaviours: Condition-specific behaviours
Intervention analysed in the study: Monitoring and emotional-based behavioural techniques Intervention components: E+MT+EB
See more
Setting of implementation: Home-care, Outpatient care (hospital) Professionals delivering the intervention: Educator Targeted self-management behaviours: Condition-specific behaviours, Handling /managing emotions, Physical activity /exercise, Physical management

Outcomes measured in the study

Outcome Measure Tool
COPD symptoms (short term) Dyspnea or breathlessness Modified Medical Research Council (MMRC)
COPD symptoms (short term) Dyspnea or breathlessness Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI)
COPD symptoms (short term) Dyspnea or breathlessness Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index (BODE index)
COPD symptoms (short term) Dyspnea or breathlessness Borg Rating of Perceived Exertion Scale (Borg RPE or BORG CR10)
Lung Function FEV1 (% pred) - forced expiratory volume N/A
Lung Function RV/TLC - Residual volume / total lung capacity (%pred) N/A
Lung Function DLCO - Diffusing capacity of the lungs for carbon monoxide (%pred) N/A
Lung Function Respiratory status - Max inspiratory pressure N/A
Physical activity / Muscle strenght Exercise capacity 6-min walking test (6MWT)
Qualiy of life Quality of life (specific-disease instruments) N/A
Qualiy of life Quality of life (specific-disease instruments) N/A

Patient characteristics

Age: 68.0 years (+/- a standard deviation of 8.09) Gender: 26 females Time since diagnosis of COPD: N/A Severity of the disease: 42.49 (+/- a standard deviation of 14.54) Multi-morbidity: N/A
  • Number of co-morbidities: N/A

Level of health literacy: N/A
  • Tool: N/A

Socio-economic characteristics: N/A

Risk of Bias of this study

Outcome Random sequence generation Allocation concealment Blinding performance Blinding detection objective outcomes assessment Attrition incomplete outcome Incorrect statistical methods Recruitment bias Selective outcome reporting
COPD symptoms (short term) - Dyspnea or breathlessness
COPD symptoms (short term) - Dyspnea or breathlessness
COPD symptoms (short term) - Dyspnea or breathlessness
COPD symptoms (short term) - Dyspnea or breathlessness
Lung Function - DLCO - Diffusing capacity of the lungs for carbon monoxide (%pred)
Lung Function - FEV1 (% pred) - forced expiratory volume
Lung Function - Respiratory status - Max inspiratory pressure
Lung Function - RV/TLC - Residual volume / total lung capacity (%pred)
Physical activity / Muscle strenght - Exercise capacity
Qualiy of life - Quality of life (specific-disease instruments)
Qualiy of life - Quality of life (specific-disease instruments)